Literature DB >> 14871472

The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.

Francesco Galli1, Anna Maria Stabile, Michele Betti, Carmela Conte, Allesandra Pistilli, Mario Rende, Ardesio Floridi, Angelo Azzi.   

Abstract

It is known that gamma-tocopherol inhibits human prostate cancer cell proliferation via down-regulation of cyclin-related signalling but tocopherol and tocotrienol metabolites with a shortened phytyl chain, carboxyethyl hydroxychromans, were not previously investigated as anti-proliferative agents. In this study, the effect of the two main tocopherols, namely, alpha-tocopherol and gamma-tocopherol, and their corresponding metabolites (alpha- and gamma-carboxyethyl hydroxychromans) was studied on proliferation and cyclin D1 expression of the prostate cancer cell line PC-3. The hydrosoluble vitamin E analogues Trolox and alpha-tocopherol succinate were also tested. The most effective inhibitors of PC-3 proliferation were gamma-tocopherol and gamma-carboxyethyl hydroxychroman. Their effect was discernable at 1 microM and reached a plateau at concentrations > or = 10 microM with maximal inhibition values ranging between 70 and 82%. alpha-Tocopherol, alpha-carboxyethyl hydroxychroman, and the analogue Trolox were much less effective; a weak effect was observed for concentrations < or = 10 microM and a maximal inhibition of less than 45% was found at 50 microM concentration. PC-3 cells showed higher inhibition, particularly by the gamma derivatives, than HTB-82 and HECV cells. Tocopherols and carboxyethyl hydroxychromans exerted an inhibitory effect on cyclin D1 expression parallel to the retardation of cell growth. gamma-Carboxyethyl hydroxychroman and gamma-tocopherol showed effects also upstream of the cyclin modulation. Furthermore, the inhibition of cyclin D1 expression by gamma-carboxyethyl hydroxychroman was competed for by alpha-carboxyethyl hydroxychroman. In conclusion, this study shows that carboxyethyl hydroxychroman metabolites are as effective as their vitamin precursors to inhibit PC-3 growth by specific down-regulation of cyclin expression, with the gamma forms being the most effective ones. Although the inhibition of PC-3 cell growth and diminution of cyclin expression are clearly visible, more subtle mechanistic effects of tocopherols and their corresponding carboxyethyl hydroxychroman metabolites deserve further investigations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871472     DOI: 10.1016/j.abb.2003.11.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis.

Authors:  Qing Jiang; Jeffrey Wong; Henrik Fyrst; Julie D Saba; Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-13       Impact factor: 11.205

2.  Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials.

Authors:  Jiaqi Huang; Howard N Hodis; Stephanie J Weinstein; Wendy J Mack; Joshua N Sampson; Alison M Mondul; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-20       Impact factor: 4.254

3.  Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells.

Authors:  Dorrelyn Patacsil; Anh Thu Tran; Youn Sook Cho; Simeng Suy; Francisco Saenz; Irina Malyukova; Habtom Ressom; Sean P Collins; Robert Clarke; Deepak Kumar
Journal:  J Nutr Biochem       Date:  2011-03-22       Impact factor: 6.048

Review 4.  Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.

Authors:  Mark C Ledesma; Brittney Jung-Hynes; Travis L Schmit; Raj Kumar; Hasan Mukhtar; Nihal Ahmad
Journal:  Mol Med       Date:  2010-09-21       Impact factor: 6.354

Review 5.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

6.  Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Authors:  Brian L Lindshield; Nikki A Ford; Kirstie Canene-Adams; Alan M Diamond; Matthew A Wallig; John W Erdman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects.

Authors:  Jan Frank; Sangeun Lee; Scott W Leonard; Jeffrey K Atkinson; Afaf Kamal-Eldin; Maret G Traber
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

Review 8.  Vitamin E: a dark horse at the crossroad of cancer management.

Authors:  Eduardo Cardenas; Rita Ghosh
Journal:  Biochem Pharmacol       Date:  2013-08-03       Impact factor: 5.858

9.  Dietary terpenoids and prostate cancer chemoprevention.

Authors:  Thangaiyan Rabi; Sanjay Gupta
Journal:  Front Biosci       Date:  2008-05-01

10.  ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo.

Authors:  Yunhui Cheng; Raili Emilia Kerppola; Tom Klaus Kerppola
Journal:  Endocr Relat Cancer       Date:  2016-02-03       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.